Continuous wound infusion

A comparative study between continuous wound infusion using Bupivacaine and Bupivacaine with Dexmedetomidine on post-operative analgesia after inguinal hernia repair

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201507000961407

Enrollment

Registered

2014-12-06

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery acute post-operative pain

Interventions

normal saline group

Bupivacaine group

Bupivacaine Dexmedetomidine group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA class I and II age 18-60 either gender scheduled for open inguinal hernia repair

Exclusion criteria

Exclusion criteria: history of cardiac disease impaired renal or hepatic function coagulation disorders hypertensive patients treated with ¿-methyldopa, clonidine or ¿-adrenergic blockers using opioid or non-opioid analgesics within the previous 72 h contraindication to the study drugs.

Design outcomes

Primary

Measure	Time frame
visual analogue pain scale (VAS);rescue analgesia: pethidine consumption	—

Secondary

Measure	Time frame
mean aterial blood pressure(MAP) , heart rate (HR);adverse effects: nausea, vomiting, sedation, local anesthetic toxicity, local inflammation or infection	—

Countries

Egypt

Contacts

Public ContactShaimaa Farouk

lecturer of anesthesia and ICU, Faculty of medicine, Tanta University

ShaimaaFarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026